Search Results 741-750 of 18603 for hepatitis

  1. Combination Therapy of Acalabrutinib, Venetoclax and Durvalumab to Treat Richter Transformation - Mayo Clinic

    Hepatitis B or C serologic status: Hepatitis B surface antigen and hepatitis B PCR positive will be excluded; Hepatitis B core antibody (anti-HBc) positive ...

  2. Esophageal varices - Doctors and departments - Mayo Clinic

    ... hepatitis, Autoimmune hepatitis, Hepatocellular carcinoma, Wilson's disease, Hepatopulmonary syndrome, Primary biliary cholangitis, Portopulmonary ...

  3. Study of ISB 1342, a CD38/​CD3 Bispecific Antibody, in Subjects With Previously Treated Multiple Myeloma - Mayo Clinic

    - Seronegative for hepatitis B antigen; positive hepatitis B tests can be further evaluated by confirmatory tests, and if viral load is negative, the ...

  4. A Study to Evaluate Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant - Mayo Clinic

    Active hepatitis B virus (HBV) or hepatitis C virus infection that requires treatment or at risk for HBV reactivation. At risk for HBV reactivation is ...

  5. Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis - Mayo Clinic

    Hepatitis and fibrosis more likely related to etiologies other than NASH such as. Alcoholic steatohepatitis; Autoimmune hepatitis; Hepatitis B virus (HBV) ...

  6. Novel Study Interventions and Combinations in Participants with Colorectal Cancer - Mayo Clinic

    Participation eligibility · Have controlled hepatitis C viral load defined as undetectable hepatitis C RNA by PCR either spontaneously or in response to a ...

  7. Liver Cirrhosis Network Cohort Study (LCN-C) - Mayo Clinic

    * Current known Hepatitis C Virus (HCV) without sustained virologic response (SVR) * Current known quantifiable Hepatitis B Virus (HBV) viral DNA on therapy ...

  8. A Study of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant - Mayo Clinic

    Active hepatitis B virus (HBV) or hepatitis C virus infection that requires treatment or at risk for HBV reactivation. At risk for HBV reactivation is ...

  9. A Study to Test Nivolumab with Usual Chemotherapy Treatment or Usual Chemotherapy Treatment Alone to Treat Recurrent or Metastatic Nasopharyngeal Cancer - Mayo Clinic

    Patients who are immune to hepatitis B (anti-Hepatitis B surface antibody positive) are eligible (i.e., patients immunized against hepatitis B). In some ...

  10. Nguyen H. Tran, M.D. - Mayo Clinic Faculty Profiles

    Dr. Tran's work in this area includes evaluating viral hepatitis and liver cancer care. Improving cancer health in Southeast Asian communities. Dr. Tran ...